Laboratory Medicine ›› 2022, Vol. 37 ›› Issue (1): 91-96.DOI: 10.3969/j.issn.1673-8640.2022.01.019

Previous Articles     Next Articles

Progress on the enrichment technology of circulating tumor cells

SHEN Suya1, HUANG Jianzhao1(), LI Xiaohuai2   

  1. 1. Guizhou Provincial People's Hospital,Guiyang 550000,Guizhou,China
    2. College of Clinical Medicine,Guizhou Medical University,Guiyang 550000,Guizhou,China
  • Received:2020-08-09 Revised:2021-05-12 Online:2022-01-30 Published:2022-03-07
  • Contact: HUANG Jianzhao

Abstract:

Circulating tumor cells(CTC)are a few tumor cells that are shed from the site of a primary or metastatic tumor into the circulatory system. As such,the isolation of CTC from blood samples and their subsequent analysis are of importance not only for understanding cancer metastasis at the cellular level but also for clinical management of the disease. Since the content of CTC in blood is too scarce to be enriched,which has become the bottleneck restricting its clinical application. In recent years,with the development of separation and enrichment techniques,CTC as a tumor biomarker for disease prognosis evaluation has become a hot topic. This review aims to review the latest advances of CTC isolation technology in cancer diagnosis,introduces the application examples of this technology,and discusses its advantages and disadvantages,prospects and technical challenges,to provide a reference for follow-up research.

Key words: Circulating tumor cell, Enrichment and separation, Microfiltration

CLC Number: